Emprumapimod (PF-07265803) is an orally active and specific inhibitor of mitogen-activated protein kinase p38alpha MAPK, inhibits LPS-induced production of IL-6, and can be used to study dilated cardiomyopathy induced by the LMNA gene.
Molecular Weight:
473.52
Purity:
99.10%
CAS Number:
[765914-60-1]
Formula:
C24H29F2N5O3
Target:
p38 MAPK
T63067
* VAT and and shipping costs not included. Errors and price changes excepted
